Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients with Comorbid Bipolar Depression

Michael Poyurovsky, Abraham Weizman

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	196-197
Number of pages	2
Journal	Clinical Neuropharmacology
Volume	44
Issue number	5
DOIs	https://doi.org/10.1097/WNF.0000000000000474
State	Published - 1 Sep 2021

Access to Document

@article{3e6085fae6364221af2be2ed3d4de718,

title = "Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients with Comorbid Bipolar Depression",

author = "Michael Poyurovsky and Abraham Weizman",

year = "2021",

month = sep,

day = "1",

doi = "10.1097/WNF.0000000000000474",

language = "אנגלית",

volume = "44",

pages = "196--197",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "5",

}

TY - JOUR

T1 - Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients with Comorbid Bipolar Depression

AU - Poyurovsky, Michael

AU - Weizman, Abraham

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85116706449&partnerID=8YFLogxK

U2 - 10.1097/WNF.0000000000000474

DO - 10.1097/WNF.0000000000000474

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34456228

AN - SCOPUS:85116706449

SN - 0362-5664

VL - 44

SP - 196

EP - 197

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 5

ER -